Majorly Resurgent and Uncontrolled Diabetes During COVID19 Era, and in the Future Can Be Contained in India

Misra, Anoop

doi:10.1016/j.dsx.2021.05.015

Cited by 5 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Specifically, TB increases 2.1‐fold risk of severe COVID‐19 disease. 58 Because diabetes also increases risk of morbidity and mortality in patients with COVID‐19, 59 , 60 it is reasonable to suggest a bidirectional TB‐COVID‐19 screening, in addition to screening for diabetes, should be done, that is, COVID‐19 screening (depending on clinical symptoms and signs) for TB cases at diagnosis and TB screening for all COVID‐19 cases.…”

Section: Resultsmentioning

confidence: 99%

Diabetes and tuberculosis syndemic in India: A narrative review of facts, gaps in care and challenges

Vaishya

Misra

Vaish

et al. 2023

Journal of Diabetes

Self Cite

View full text Add to dashboard Cite

Both diabetes mellitus (DM) and tuberculosis (TB) are prevalent all across in India. TB‐DM comorbidity has emerged as a syndemic and needs more attention in India considering gaps in screening, clinical care, and research. This paper is intended to review published literature on TB and DM in India to understand the burden of the dual epidemic and its trajectory and to obtain perspectives on the gaps, constraints, and challenges in care and treatment of this dual epidemic. A literature search was carried out on PubMed, Scopus, and Google Scholar, using the key words ‘Tuberculosis’ OR ‘TB’ AND ‘Diabetes’ OR ‘Diabetes Mellitus’ AND ‘India’, focusing on the research published between the year 2000 to 2022. The prevalence of DM is high in patients with TB. Quantitative data on the epidemiological situation of TB/DM in India such as incidence, prevalence, mortality, and management are lacking. During the last 2 years convergence of TB‐DM syndemic with the COVID‐19 pandemic has increased cases with uncontrolled DM but also made coordinated control of TB‐DM operationally difficult and of low effectiveness. Research regarding TB‐DM comorbidity is required in the context of epidemiology and management. Detection and bidirectional screening are aggressively warranted. Management of DM in those with TB‐DM comorbidity needs more efforts, including training and supervision of frontline workers.

show abstract

Section: Resultsmentioning

confidence: 99%